✦ LIBER ✦

Considerations in the development of circulating tumor cell technology for clinical use

✍ Scribed by David R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, Carolyn Compton, Massimo Cristofanilli, Albert Deisseroth, Daniel F Hayes, Gordon Kapke, Prasanna Kumar, Jerry SH Lee, Minetta C Liu, Robert McCormack, Stanislaw Mikulski, Larry Nagahara, Klaus Pantel, et al

Book ID: 119905213
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 306 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-138

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Considerations for the Clinical Developm

Considerations for the Clinical Development of Cytokine Gene-Transduced Tumor Cell Vaccines

✍ Elizabeth M. Jaffee; Drew M. Pardoll 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Use of Circulating Tumor Cell Technology

Use of Circulating Tumor Cell Technology (CELLSEARCH) for the Diagnosis of Malignant Pleural Effusions

✍ Schwed Lustgarten, Daniel E.; Thompson, Jeffrey; Yu, Gordon; Vachani, Anil; Vaid 📂 Article 📅 2013 🏛 American Thoracic Society 🌐 English ⚖ 893 KB

Rapid translation of circulating tumor c

Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements

✍ King, Jonathan D. ;Casavant, Benjamin P. ;Lang, Joshua M. 📂 Article 📅 2014 🏛 Royal Society of Chemistry 🌐 English ⚖ 176 KB

The development of composite circulating

The development of composite circulating biomarker models for use in anticancer drug clinical development

✍ Lee J. Lancashire; Darren L. Roberts; Caroline Dive; Andrew G. Renehan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulin‐

Technologies for label-free separation o

Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments

✍ Jin, Chao ;McFaul, Sarah M. ;Duffy, Simon P. ;Deng, Xiaoyan ;Tavassoli, Peyman ; 📂 Article 📅 2014 🏛 Royal Society of Chemistry 🌐 English ⚖ 883 KB

User-defined protein marker assay develo

User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system

✍ Lori E. Lowes; Benjamin D. Hedley; Mike Keeney; Alison L. Allan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 969 KB